Margo Sorgman was diagnosed with an MPN, polycythemia vera (PV), just a few months ago at the age of 71. She shares her story of learning about the condition, meeting with Dr. Brady Stein, and how she’s doing today.
Jeff Folloder, a husband, father, son, and cancer survivor, discusses his own personal journey with CLL and his philanthropic efforts in the cancer community.
Why do I have lung cancer if I’ve never smoked? Dianne Stewart, a stage IV cancer patient, asked herself this question following her diagnosis. Hear about her initial stage of shock and denial and her advice for others.
March 25, 2014
Dr. Ruben Mesa describes various tools used to better predict disease behavior, specifically symptoms, among polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis. Mesa lays out the overall survival rates based on data collected and what we’ve learned. Dr. Jorge Cortes discusses the scores or “median survival” and how they are used to calculate statistics for survival. Both help us understand the efficacy and limitations of these tools.
View more programs featuring
Ruben Mesa, M.D. and Jorge Cortes, M.D.
Produced in association with
MD Anderson Cancer Center
Ruben Mesa, M.D.
Jorge Cortes, M.D.
Be the first to know about new programs and information with email alerts.
Mayo Clinic expert Dr. Ruben Mesa shares his thoughts on how treatment and research can be further improved for patients living with MPNs.
Published: February 3, 2014
How early should a JAK2 inhibitor be prescribed for myelofibrosis or other myeloproliferative conditions? Approved and investigational JAK2 inhibitors are now being used by patients with more advanced and aggressive MPNs, but not as often in earlier stages. Watch now as Dr. Srdan Verstovsek gives his opinion on how JAK inhibitors should be used.
Published: May 17, 2013
Is it possible to pinpoint the source of symptoms in MPNs? Not always, according to Drs. Ruben Mesa and Jorge Cortes. Both experts focus on understanding disease burden among MPNs.
Published: March 18, 2014
By Andrew Schorr